Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Nitric oxide as a target in stroke therapy

Feb. 6, 1998

Migranal Nasal Spray now available in U.S.

Feb. 6, 1998

NIF is neuroprotective in rat model of ischemia

Feb. 5, 1998

Algos initiates FDA approval process for MorphiDex

Feb. 5, 1998

Preclinical pharmacology of ebselen described in depth

Feb. 5, 1998

Novel PTK-related technology from Genentech and collaborators

Feb. 5, 1998

Potent SK(Ca) channel blocker prepared by European university researchers

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

Neuroprotective activity described for CoCensys neurosteroid

Feb. 4, 1998

Neuroprotective effects of IL-1ra

Feb. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...